
GFO Issue 79, Article Number: 2
Sub-title :
ABSTRACT
ABSTRACT
A detailed listing and analysis is provided of which Round 7 proposals have been approved.
Based on advise from the Technical Review Panel (TRP), the Board divided eligible Round 7 proposals into five Categories, as follows:
- Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 8 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
- Category 2: Proposals that are provisionally approved subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to provide an initial detailed response to the TRP queries, and a further 3 months to obtain the final TRP approval should further clarifications be requested). The primary reviewer and secondary reviewer as well as TRP Chair and /or Vice-Chair need to give final approval.
- Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
- Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in some future Round following major revision.
- Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.
The number of Round 7 grants per Category was as follows:
Table 5: Round 7 results by Category
Category
Number of proposals
Budget
Years 1-2
Budget
Years 1-5
Approved: Category 1
5
$53 m.
$136 m.
Approved: Category 2
42
$657 m.
$1,618 m.
Approved: Category 2B
26
$408 m.
$1,009 m.
Subtotal: All Approved Proposals:
73
$1,119 m.
$2,762 m.
Not Approved: Category 3
74
$1,234 m.
$2,939 m.
Not Approved: Category 4
3
$45 m.
$113 m.
Subtotal: All Non-Approved Proposals:
77
$1,279 m.
$3,052 m.
Total: All Proposals
150
$2,397 m.
$5,814 m.
Round 7 results by applicant were as in Tables 6 and 7, below. Grants approved in Euros have had their values converted to US dollars at US $1.44092 per Euro, which is the UN official exchange rate that applied on 1 November.
Table 6: Round 7 results for country-level applicants
Country
Applicant
Decision
Component
Budget
Years 1-2
Budget
Years 1-5
Afghanistan
CCM
Approved: Category 2B
HIV/AIDS
$4,767,953
$10,077,515
Afghanistan
CCM
Not approved: Category 3
TB
$16,761,247
$35,769,214
Angola
CCM
Approved: Category 2B
Malaria
$32,512,650
$78,470,624
Angola
CCM
Not approved: Category 3
TB
$8,795,159
$16,323,433
Armenia
CCM
Not approved: Category 3
HIV/AIDS
$8,387,015
$25,006,079
Armenia
CCM
Not approved: Category 3
TB
$3,224,782
$7,909,924
Azerbaijan
CCM
Not approved: Category 3
Malaria
$3,665,922
$6,321,003
Azerbaijan
CCM
Approved: Category 1
TB
$6,573,412
$23,591,627
Bangladesh
CCM
Not approved: Category 3
HIV/AIDS
$21,082,381
$53,393,592
Bangladesh
CCM
Not approved: Category 3
Malaria
$8,133,847
$19,596,925
Benin
CCM
Not approved: Category 3
HIV/AIDS
$26,651,624
$63,423,329
Benin
CCM
Approved: Category 2B
Malaria
$13,385,305
$22,372,872
Bhutan
CCM
Approved: Category 2B
Malaria
$1,923,869
$2,932,772
Bolivia
CCM
Not approved: Category 3
Malaria
$6,637,684
$11,810,260
Botswana
CCM
Not approved: Category 3
HIV/AIDS
$18,105,960
$36,911,669
Burkina Faso
CCM
Approved: Category 2
Malaria
$17,442,345
$37,849,810
Burundi
CCM
Not approved: Category 3
HIV/AIDS
$28,571,856
$84,090,448
Burundi
CCM
Approved: Category 2B
TB
$4,018,177
$10,940,597
Cambodia
CCM
Approved: Category 2
HIV/AIDS
$23,857,767
$46,693,979
Cambodia
CCM
Not approved: Category 3
TB
$8,707,480
$21,732,519
Cameroon
CCM
Not approved: Category 3
HIV/AIDS
$36,832,111
$81,489,056
Cameroon
CCM
Not approved: Category 3
Malaria
$13,809,496
$57,156,479
Cameroon
CCM
Not approved: Category 3
TB
$6,024,082
$11,068,029
Cape Verde
CCM
Not approved: Category 3
HIV/AIDS
$6,311,201
$11,657,810
Central African Republic
CCM
Approved: Category 2
HIV/AIDS
$15,891,199
$43,999,379
Chad
CCM
Not approved: Category 3
HIV/AIDS
$13,252,627
$30,838,419
Chad
CCM
Approved: Category 2
Malaria
$10,477,631
$27,497,966
China
CCM
Not approved: Category 3
HIV/AIDS
$11,848,160
$21,636,832
China
CCM
Not approved: Category 3
Malaria
$6,018,460
$11,957,891
China
CCM
Approved: Category 2B
TB
$5,313,264
$49,281,105
Colombia
CCM
Not approved: Category 3
HIV/AIDS
$16,436,446
$37,759,055
Colombia
CCM
Not approved: Category 3
Malaria
$30,555,478
$42,799,426
Colombia
CCM
Not approved: Category 3
TB
$8,211,140
$15,941,101
Comoros
CCM
Not approved: Category 3
HIV/AIDS
$1,354,097
$3,041,683
Comoros
CCM
Not approved: Category 3
Malaria
$6,378,215
$14,722,607
Côte d'Ivoire
CCM
Not approved: Category 3
HIV/AIDS
$48,843,161
$129,272,746
Cuba
CCM
Approved: Category 2B
TB
$5,455,745
$7,871,598
DR Congo
CCM
Approved: Category 2
HIV/AIDS
$22,675,189
$71,403,216
DR Congo
CCM
Not approved: Category 3
Malaria
$19,701,102
$62,841,029
Dominican Republic
CCM
Not approved: Category 3
HIV/AIDS
$23,050,027
$49,392,551
Dominican Republic
CCM
Approved: Category 2
TB
$5,650,022
$14,223,859
Ecuador
CCM
Not approved: Category 3
HIV/AIDS
$12,917,989
$22,638,882
El Salvador
CCM
Approved: Category 2
HIV/AIDS
$10,618,394
$24,866,086
El Salvador
CCM
Not approved: Category 3
TB
$3,204,120
$6,868,440
Eritrea
CCM
Not approved: Category 3
HIV/AIDS
$5,278,780
$25,283,136
Ethiopia
CCM
Approved: Category 2B
HIV/AIDS
$64,959,699
$106,261,584
Ethiopia
CCM
Not approved: Category 3
Malaria
$16,971,461
$99,572,846
Gaza
Non-CCM (AMAN - NGO)
Not approved: Category 3
TB
$417,844
$417,844
Georgia
CCM
Not approved: Category 3
HIV/AIDS
$18,350,889
$30,290,945
Ghana
CCM
Not approved: Category 3
Malaria
$24,012,027
$114,757,578
Guinea Bissau
CCM
Approved: Category 2B
HIV/AIDS
$14,221,990
$44,154,072
Guinea Bissau
CCM
Not approved: Category 3
TB
$3,672,828
$8,565,738
Guyana
CCM
Not approved: Category 3
HIV/AIDS
$13,000,000
$37,000,000
Guyana
CCM
Approved: Category 2
Malaria
$1,844,002
$3,670,627
Haiti
CCM
Approved: Category 2
HIV/AIDS
$6,199,554
$15,000,000
India
CCM
Approved: Category 2
HIV/AIDS
$31,037,097
$88,173,118
Indonesia
CCM
Not approved: Category 3
HIV/AIDS
$17,211,566
$57,306,841
Indonesia
CCM
Not approved: Category 3
Malaria
$46,973,341
$60,873,895
Iran
CCM
Not approved: Category 3
HIV/AIDS
$31,606,904
$48,933,717
Iran
CCM
Approved: Category 2B
Malaria
$5,832,844
$11,634,027
Iran
CCM
Approved: Category 2
TB
$14,249,166
$24,019,635
Jamaica
CCM
Approved: Category 2
HIV/AIDS
$15,219,930
$44,176,429
Kazakhstan
CCM
Approved: Category 2
HIV/AIDS
$12,964,117
$35,335,883
Kenya
CCM
Approved: Category 2
HIV/AIDS
$47,145,912
$132,269,783
Kenya
CCM
Not approved: Category 3
Malaria
$17,983,932
$59,014,190
Kosovo
CCM
Approved: Category 1
HIV/AIDS
$2,433,080
$6,655,143
Kyrgyz Republic
CCM
Approved: Category 1
HIV/AIDS
$11,845,091
$28,209,191
Lao PDR
CCM
Approved: Category 2
Malaria
$7,058,890
$25,665,343
Lao PDR
CCM
Approved: Category 2
TB
$4,368,246
$10,905,922
Lesotho
CCM
Approved: Category 2
HIV/AIDS
$10,626,665
$33,264,808
Liberia
CCM
Approved: Category 2B
Malaria
$12,695,907
$37,380,198
Liberia
CCM
Approved: Category 2
TB
$6,408,872
$14,531,896
Macedonia
CCM
Approved: Category 2
HIV/AIDS
$4,245,932
$9,940,432
Madagascar
CCM
Not approved: Category 3
HIV/AIDS
$10,097,290
$26,865,626
Madagascar
CCM
Approved: Category 2
Malaria
$26,095,449
$69,199,450
Malawi
CCM
Approved: Category 2
HIV/AIDS
$15,078,417
$36,025,380
Malawi
CCM
Approved: Category 2
Malaria
$34,839,182
$62,000,902
Malawi
CCM
Approved: Category 2
TB
$7,802,037
$17,961,859
Mali
CCM
Approved: Category 2B
TB
$4,412,826
$11,793,764
Mongolia
CCM
Approved: Category 2
HIV/AIDS
$1,440,102
$2,946,767
Mozambique
CCM
Approved: Category 2
TB
$6,735,303
$20,983,828
Nepal
CCM
Approved: Category 2
HIV/AIDS
$12,321,512
$36,620,119
Nepal
CCM
Approved: Category 2B
Malaria
$9,735,739
$25,757,233
Nepal
CCM
Approved: Category 2
TB
$4,740,974
$15,506,566
Nicaragua
CCM
Not approved: Category 3
HIV/AIDS
$10,252,517
$21,082,833
Nicaragua
CCM
Approved: Category 2B
Malaria
$2,868,542
$5,729,504
Nicaragua
CCM
Not approved: Category 3
TB
$2,333,609
$3,895,056
Niger
CCM
Approved: Category 2B
HIV/AIDS
$15,048,604
$43,011,335
Niger
CCM
Approved: Category 2B
Malaria
$31,686,047
$42,982,108
Nigeria
CCM
Not approved: Category 3
HIV/AIDS
$38,263,602
$120,564,672
Nigeria
CCM
Not approved: Category 3
Malaria
$124,669,413
$216,781,423
Nigeria
CCM
Not approved: Category 3
TB
$24,273,085
$41,830,161
Pakistan
CCM
Not approved: Category 3
HIV/AIDS
$17,411,393
$51,177,389
Pakistan
CCM
Approved: Category 2B
Malaria
$12,886,680
$21,557,705
Pakistan
CCM
Not approved: Category 3
TB
$14,617,779
$25,247,993
Paraguay
CCM
Approved: Category 2B
TB
$2,149,206
$6,018,754
Russian Federation (Tomsk Oblast)
Sub-CCM
Not approved: Category 3
TB
$7,459,895
$14,597,093
Rwanda
CCM
Approved: Category 2
HIV/AIDS
$63,978,048
$137,268,168
Sao Tome and Principe
CCM
Approved: Category 2
Malaria
$4,234,962
$8,698,492
Senegal
CCM
Approved: Category 2
Malaria
$30,487,664
$64,953,351
Senegal
CCM
Approved: Category 2B
TB
$4,494,276
$9,340,456
Sierra Leone
CCM
Approved: Category 2
Malaria
$10,011,250
$26,108,640
Sierra Leone
CCM
Approved: Category 2
TB
$4,340,048
$10,530,635
Solomon Islands
CCM
Not approved: Category 3
HIV/AIDS
$1,967,144
$7,405,890
Solomon Islands
CCM
Not approved: Category 3
TB
$760,169
$1,444,217
Somalia
Non-CCM
Approved: Category 2B
TB
$8,732,844
$29,353,798
South Africa
CCM
Not approved: Category 3
HIV/AIDS
$28,129,471
$64,469,441
Sri Lanka
CCM
Not approved: Category 3
HIV/AIDS
$6,417,592
$11,163,146
Sri Lanka
CCM
Not approved: Category 3
Malaria
$8,548,350
$14,577,550
Sri Lanka
CCM
Not approved: Category 4
TB
$3,102,868
$5,331,894
Sudan (Northern Sector)
CCM
Not approved: Category 3
HIV/AIDS
$17,632,367
$25,081,867
Sudan (Northern Sector)
CCM
Approved: Category 2
Malaria
$38,296,873
$94,762,531
Sudan (Northern Sector)
CCM
Not approved: Category 3
TB
$5,118,106
$11,250,611
Sudan (Southern Sector)
Sub-CCM
Approved: Category 2
Malaria
$35,008,693
$75,927,636
Sudan (Southern Sector)
Sub-CCM
Approved: Category 2
TB
$7,061,337
$17,598,282
Suriname
CCM
Not approved: Category 3
HIV/AIDS
$4,759,904
$9,186,152
Suriname
CCM
Approved: Category 2
Malaria
$2,409,000
$4,232,000
Swaziland
CCM
Approved: Category 2
HIV/AIDS
$28,380,316
$81,866,490
Tanzania
CCM
Not approved: Category 3
HIV/AIDS
$38,764,078
$103,554,555
Tanzania
CCM
Approved: Category 1
Malaria
$20,707,304
$52,545,829
Thailand
CCM
Not approved: Category 3
HIV/AIDS
$23,383,543
$66,182,975
Thailand
CCM
Approved: Category 1
Malaria
$11,939,346
$24,689,670
Thailand
CCM
Not approved: Category 3
TB
$6,491,515
$19,864,434
Timor-Leste
CCM
Approved: Category 2
Malaria
$6,866,605
$10,328,742
Timor-Leste
CCM
Approved: Category 2B
TB
$2,895,449
$7,011,931
Togo
CCM
Not approved: Category 3
HIV/AIDS
$32,449,869
$84,200,275
Uganda
CCM
Approved: Category 2B
HIV/AIDS
$84,358,482
$268,800,980
Uganda
CCM
Approved: Category 2B
Malaria
$51,422,198
$125,571,990
Uganda
CCM
Not approved: Category 3
TB
$2,416,931
$5,144,047
Ukraine
CCM
Not approved: Category 3
TB
$52,827,422
$94,682,871
Uzbekistan
CCM
Not approved: Category 3
HIV/AIDS
$7,154,490
$16,148,648
Uzbekistan
CCM
Not approved: Category 3
Malaria
$2,213,257
$5,071,312
Uzbekistan
CCM
Not approved: Category 3
TB
$9,538,632
$30,154,483
Vietnam
CCM
Not approved: Category 3
HIV/AIDS
$13,154,988
$38,347,083
Vietnam
CCM
Approved: Category 2
Malaria
$11,926,329
$29,977,899
West Bank and Gaza
Non-CCM (UN Theme Group on HIV/AIDS)
Approved: Category 2B
HIV/AIDS
$5,014,330
$10,832,405
Yemen
CCM
Approved: Category 2
Malaria
$8,140,793
$27,862,946
Zambia
CCM
Approved: Category 2
Malaria
$18,003,233
$37,502,022
Zambia
CCM
Not approved: Category 3
TB
$4,112,419
$24,959,034
Zanzibar
CCM
Not approved: Category 3
Malaria
$5,961,504
$19,608,490
Zimbabwe
CCM
Not approved: Category 3
Malaria
$26,225,739
$48,511,090
Zimbabwe
CCM
Not approved: Category 3
TB
$11,247,899
$25,586,720
Table 7: Round 7 results for regional applicants
Region
Applicant
Decision
Component
Budget
Years 1-2
Budget
Years 1-5
Cook Islands, Micronesia, Kiribati, Marshall Islands, Nauru, Nieu, Palau, Samoa, Solomon Islands, Tonga, Tuvalu and Vanuatu
Regional Coordinating Mechanism (MCWP)
Approved: Category 2
HIV/AIDS
$10,710,982
$25,295,384
Cook Islands, Micronesia, Kiribati, Marshall Islands, Nauru, Nieu, Palau, Samoa, Solomon Islands, Tonga, Tuvalu and Vanuatu
Regional Coordinating Mechanism (MCWP)
Approved: Category 2B
TB
$5,684,067
$13,353,203
Bangladesh, India and Nepal
Regional Org. (CARE)
Not approved: Category 3
HIV/AIDS
$23,893,276
$74,571,728
Bangladesh, India and Nepal
Regional Org. (PSI)
Not approved: Category 3
HIV/AIDS
$11,058,387
$30,192,838
Bolivia, Colombia, Ecuador, Paraguay, Peru and Uruguay
Regional Org. (REDLA+)
Not approved: Category 3
HIV/AIDS
$21,138,400
$50,059,500
Brunei, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam
Regional Org. (ASEAN)
Not approved: Category 4
HIV/AIDS
$34,807,826
$89,393,697
Cameroon, CAR, Congo, Gabon, Equatorial Guinea
Regional Org. (CEEAC)
Not approved: Category 4
HIV/AIDS
$7,170,604
$18,109,467
El Salvador, Honduras, Nicaragua and Panama
Regional Org. (REDCA+)
Approved: Category 2B
HIV/AIDS
$1,849,200
$6,369,850
For further details on the approved proposals, see www.theglobalfund.org/en/about/board/sixteenth; for the non-approved proposals, see www.theglobalfund.org/en/apply/current/round7_notapproved. The full text of each Round 7 proposal is accessible at these links.
An applicant may appeal the board's decision if the applicant submitted an eligible proposal for a particular component in both Round 6 and Round 7 and was not approved in either case. The appeal must show that the recommendation made by the TRP regarding the Round 7 proposal was based on a "significant and obvious" error. The appeal must be filed with the Secretariat no later than 28 days from when the applicant receives written notice from the Secretariat regarding the board's Round 7 decision. For further details regarding the appeals procedure, see www.theglobalfund.org/en/apply/proposals/appeals.
- Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 8 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
- Category 2: Proposals that are provisionally approved subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to provide an initial detailed response to the TRP queries, and a further 3 months to obtain the final TRP approval should further clarifications be requested). The primary reviewer and secondary reviewer as well as TRP Chair and /or Vice-Chair need to give final approval.
- Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
- Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in some future Round following major revision.
- Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.
Table 5: Round 7 results by Category
Category |
Number of proposals |
Budget Years 1-2 |
Budget Years 1-5 |
Approved: Category 1 | 5 | $53 m. | $136 m. |
Approved: Category 2 | 42 | $657 m. | $1,618 m. |
Approved: Category 2B | 26 | $408 m. | $1,009 m. |
Subtotal: All Approved Proposals: |
73 |
$1,119 m. |
$2,762 m. |
Not Approved: Category 3 | 74 | $1,234 m. | $2,939 m. |
Not Approved: Category 4 | 3 | $45 m. | $113 m. |
Subtotal: All Non-Approved Proposals: |
77 |
$1,279 m. |
$3,052 m. |
Total: All Proposals |
150 |
$2,397 m. |
$5,814 m. |
Round 7 results by applicant were as in Tables 6 and 7, below. Grants approved in Euros have had their values converted to US dollars at US $1.44092 per Euro, which is the UN official exchange rate that applied on 1 November.
Table 6: Round 7 results for country-level applicants
Country |
Applicant |
Decision |
Component |
Budget Years 1-2 |
Budget Years 1-5 |
Afghanistan |
CCM |
Approved: Category 2B |
HIV/AIDS |
$4,767,953 |
$10,077,515 |
Afghanistan | CCM | Not approved: Category 3 | TB | $16,761,247 | $35,769,214 |
Angola |
CCM |
Approved: Category 2B |
Malaria |
$32,512,650 |
$78,470,624 |
Angola | CCM | Not approved: Category 3 | TB | $8,795,159 | $16,323,433 |
Armenia | CCM | Not approved: Category 3 | HIV/AIDS | $8,387,015 | $25,006,079 |
Armenia | CCM | Not approved: Category 3 | TB | $3,224,782 | $7,909,924 |
Azerbaijan | CCM | Not approved: Category 3 | Malaria | $3,665,922 | $6,321,003 |
Azerbaijan |
CCM |
Approved: Category 1 |
TB |
$6,573,412 |
$23,591,627 |
Bangladesh | CCM | Not approved: Category 3 | HIV/AIDS | $21,082,381 | $53,393,592 |
Bangladesh | CCM | Not approved: Category 3 | Malaria | $8,133,847 | $19,596,925 |
Benin | CCM | Not approved: Category 3 | HIV/AIDS | $26,651,624 | $63,423,329 |
Benin |
CCM |
Approved: Category 2B |
Malaria |
$13,385,305 |
$22,372,872 |
Bhutan |
CCM |
Approved: Category 2B |
Malaria |
$1,923,869 |
$2,932,772 |
Bolivia | CCM | Not approved: Category 3 | Malaria | $6,637,684 | $11,810,260 |
Botswana | CCM | Not approved: Category 3 | HIV/AIDS | $18,105,960 | $36,911,669 |
Burkina Faso |
CCM |
Approved: Category 2 |
Malaria |
$17,442,345 |
$37,849,810 |
Burundi | CCM | Not approved: Category 3 | HIV/AIDS | $28,571,856 | $84,090,448 |
Burundi |
CCM |
Approved: Category 2B |
TB |
$4,018,177 |
$10,940,597 |
Cambodia |
CCM |
Approved: Category 2 |
HIV/AIDS |
$23,857,767 |
$46,693,979 |
Cambodia | CCM | Not approved: Category 3 | TB | $8,707,480 | $21,732,519 |
Cameroon | CCM | Not approved: Category 3 | HIV/AIDS | $36,832,111 | $81,489,056 |
Cameroon | CCM | Not approved: Category 3 | Malaria | $13,809,496 | $57,156,479 |
Cameroon | CCM | Not approved: Category 3 | TB | $6,024,082 | $11,068,029 |
Cape Verde | CCM | Not approved: Category 3 | HIV/AIDS | $6,311,201 | $11,657,810 |
Central African Republic |
CCM |
Approved: Category 2 |
HIV/AIDS |
$15,891,199 |
$43,999,379 |
Chad | CCM | Not approved: Category 3 | HIV/AIDS | $13,252,627 | $30,838,419 |
Chad |
CCM |
Approved: Category 2 |
Malaria |
$10,477,631 |
$27,497,966 |
China | CCM | Not approved: Category 3 | HIV/AIDS | $11,848,160 | $21,636,832 |
China | CCM | Not approved: Category 3 | Malaria | $6,018,460 | $11,957,891 |
China |
CCM |
Approved: Category 2B |
TB |
$5,313,264 |
$49,281,105 |
Colombia | CCM | Not approved: Category 3 | HIV/AIDS | $16,436,446 | $37,759,055 |
Colombia | CCM | Not approved: Category 3 | Malaria | $30,555,478 | $42,799,426 |
Colombia | CCM | Not approved: Category 3 | TB | $8,211,140 | $15,941,101 |
Comoros | CCM | Not approved: Category 3 | HIV/AIDS | $1,354,097 | $3,041,683 |
Comoros | CCM | Not approved: Category 3 | Malaria | $6,378,215 | $14,722,607 |
Côte d'Ivoire | CCM | Not approved: Category 3 | HIV/AIDS | $48,843,161 | $129,272,746 |
Cuba |
CCM |
Approved: Category 2B |
TB |
$5,455,745 |
$7,871,598 |
DR Congo |
CCM |
Approved: Category 2 |
HIV/AIDS |
$22,675,189 |
$71,403,216 |
DR Congo | CCM | Not approved: Category 3 | Malaria | $19,701,102 | $62,841,029 |
Dominican Republic | CCM | Not approved: Category 3 | HIV/AIDS | $23,050,027 | $49,392,551 |
Dominican Republic |
CCM |
Approved: Category 2 |
TB |
$5,650,022 |
$14,223,859 |
Ecuador | CCM | Not approved: Category 3 | HIV/AIDS | $12,917,989 | $22,638,882 |
El Salvador |
CCM |
Approved: Category 2 |
HIV/AIDS |
$10,618,394 |
$24,866,086 |
El Salvador | CCM | Not approved: Category 3 | TB | $3,204,120 | $6,868,440 |
Eritrea | CCM | Not approved: Category 3 | HIV/AIDS | $5,278,780 | $25,283,136 |
Ethiopia |
CCM |
Approved: Category 2B |
HIV/AIDS |
$64,959,699 |
$106,261,584 |
Ethiopia | CCM | Not approved: Category 3 | Malaria | $16,971,461 | $99,572,846 |
Gaza | Non-CCM (AMAN - NGO) | Not approved: Category 3 | TB | $417,844 | $417,844 |
Georgia | CCM | Not approved: Category 3 | HIV/AIDS | $18,350,889 | $30,290,945 |
Ghana | CCM | Not approved: Category 3 | Malaria | $24,012,027 | $114,757,578 |
Guinea Bissau |
CCM |
Approved: Category 2B |
HIV/AIDS |
$14,221,990 |
$44,154,072 |
Guinea Bissau | CCM | Not approved: Category 3 | TB | $3,672,828 | $8,565,738 |
Guyana | CCM | Not approved: Category 3 | HIV/AIDS | $13,000,000 | $37,000,000 |
Guyana |
CCM |
Approved: Category 2 |
Malaria |
$1,844,002 |
$3,670,627 |
Haiti |
CCM |
Approved: Category 2 |
HIV/AIDS |
$6,199,554 |
$15,000,000 |
India |
CCM |
Approved: Category 2 |
HIV/AIDS |
$31,037,097 |
$88,173,118 |
Indonesia | CCM | Not approved: Category 3 | HIV/AIDS | $17,211,566 | $57,306,841 |
Indonesia | CCM | Not approved: Category 3 | Malaria | $46,973,341 | $60,873,895 |
Iran | CCM | Not approved: Category 3 | HIV/AIDS | $31,606,904 | $48,933,717 |
Iran |
CCM |
Approved: Category 2B |
Malaria |
$5,832,844 |
$11,634,027 |
Iran |
CCM |
Approved: Category 2 |
TB |
$14,249,166 |
$24,019,635 |
Jamaica |
CCM |
Approved: Category 2 |
HIV/AIDS |
$15,219,930 |
$44,176,429 |
Kazakhstan |
CCM |
Approved: Category 2 |
HIV/AIDS |
$12,964,117 |
$35,335,883 |
Kenya |
CCM |
Approved: Category 2 |
HIV/AIDS |
$47,145,912 |
$132,269,783 |
Kenya | CCM | Not approved: Category 3 | Malaria | $17,983,932 | $59,014,190 |
Kosovo |
CCM |
Approved: Category 1 |
HIV/AIDS |
$2,433,080 |
$6,655,143 |
Kyrgyz Republic |
CCM |
Approved: Category 1 |
HIV/AIDS |
$11,845,091 |
$28,209,191 |
Lao PDR |
CCM |
Approved: Category 2 |
Malaria |
$7,058,890 |
$25,665,343 |
Lao PDR |
CCM |
Approved: Category 2 |
TB |
$4,368,246 |
$10,905,922 |
Lesotho |
CCM |
Approved: Category 2 |
HIV/AIDS |
$10,626,665 |
$33,264,808 |
Liberia |
CCM |
Approved: Category 2B |
Malaria |
$12,695,907 |
$37,380,198 |
Liberia |
CCM |
Approved: Category 2 |
TB |
$6,408,872 |
$14,531,896 |
Macedonia |
CCM |
Approved: Category 2 |
HIV/AIDS |
$4,245,932 |
$9,940,432 |
Madagascar | CCM | Not approved: Category 3 | HIV/AIDS | $10,097,290 | $26,865,626 |
Madagascar |
CCM |
Approved: Category 2 |
Malaria |
$26,095,449 |
$69,199,450 |
Malawi |
CCM |
Approved: Category 2 |
HIV/AIDS |
$15,078,417 |
$36,025,380 |
Malawi |
CCM |
Approved: Category 2 |
Malaria |
$34,839,182 |
$62,000,902 |
Malawi |
CCM |
Approved: Category 2 |
TB |
$7,802,037 |
$17,961,859 |
Mali |
CCM |
Approved: Category 2B |
TB |
$4,412,826 |
$11,793,764 |
Mongolia |
CCM |
Approved: Category 2 |
HIV/AIDS |
$1,440,102 |
$2,946,767 |
Mozambique |
CCM |
Approved: Category 2 |
TB |
$6,735,303 |
$20,983,828 |
Nepal |
CCM |
Approved: Category 2 |
HIV/AIDS |
$12,321,512 |
$36,620,119 |
Nepal |
CCM |
Approved: Category 2B |
Malaria |
$9,735,739 |
$25,757,233 |
Nepal |
CCM |
Approved: Category 2 |
TB |
$4,740,974 |
$15,506,566 |
Nicaragua | CCM | Not approved: Category 3 | HIV/AIDS | $10,252,517 | $21,082,833 |
Nicaragua |
CCM |
Approved: Category 2B |
Malaria |
$2,868,542 |
$5,729,504 |
Nicaragua | CCM | Not approved: Category 3 | TB | $2,333,609 | $3,895,056 |
Niger |
CCM |
Approved: Category 2B |
HIV/AIDS |
$15,048,604 |
$43,011,335 |
Niger |
CCM |
Approved: Category 2B |
Malaria |
$31,686,047 |
$42,982,108 |
Nigeria | CCM | Not approved: Category 3 | HIV/AIDS | $38,263,602 | $120,564,672 |
Nigeria | CCM | Not approved: Category 3 | Malaria | $124,669,413 | $216,781,423 |
Nigeria | CCM | Not approved: Category 3 | TB | $24,273,085 | $41,830,161 |
Pakistan | CCM | Not approved: Category 3 | HIV/AIDS | $17,411,393 | $51,177,389 |
Pakistan |
CCM |
Approved: Category 2B |
Malaria |
$12,886,680 |
$21,557,705 |
Pakistan | CCM | Not approved: Category 3 | TB | $14,617,779 | $25,247,993 |
Paraguay |
CCM |
Approved: Category 2B |
TB |
$2,149,206 |
$6,018,754 |
Russian Federation (Tomsk Oblast) | Sub-CCM | Not approved: Category 3 | TB | $7,459,895 | $14,597,093 |
Rwanda |
CCM |
Approved: Category 2 |
HIV/AIDS |
$63,978,048 |
$137,268,168 |
Sao Tome and Principe |
CCM |
Approved: Category 2 |
Malaria |
$4,234,962 |
$8,698,492 |
Senegal |
CCM |
Approved: Category 2 |
Malaria |
$30,487,664 |
$64,953,351 |
Senegal |
CCM |
Approved: Category 2B |
TB |
$4,494,276 |
$9,340,456 |
Sierra Leone |
CCM |
Approved: Category 2 |
Malaria |
$10,011,250 |
$26,108,640 |
Sierra Leone |
CCM |
Approved: Category 2 |
TB |
$4,340,048 |
$10,530,635 |
Solomon Islands | CCM | Not approved: Category 3 | HIV/AIDS | $1,967,144 | $7,405,890 |
Solomon Islands | CCM | Not approved: Category 3 | TB | $760,169 | $1,444,217 |
Somalia |
Non-CCM |
Approved: Category 2B |
TB |
$8,732,844 |
$29,353,798 |
South Africa | CCM | Not approved: Category 3 | HIV/AIDS | $28,129,471 | $64,469,441 |
Sri Lanka | CCM | Not approved: Category 3 | HIV/AIDS | $6,417,592 | $11,163,146 |
Sri Lanka | CCM | Not approved: Category 3 | Malaria | $8,548,350 | $14,577,550 |
Sri Lanka | CCM | Not approved: Category 4 | TB | $3,102,868 | $5,331,894 |
Sudan (Northern Sector) | CCM | Not approved: Category 3 | HIV/AIDS | $17,632,367 | $25,081,867 |
Sudan (Northern Sector) |
CCM |
Approved: Category 2 |
Malaria |
$38,296,873 |
$94,762,531 |
Sudan (Northern Sector) | CCM | Not approved: Category 3 | TB | $5,118,106 | $11,250,611 |
Sudan (Southern Sector) |
Sub-CCM |
Approved: Category 2 |
Malaria |
$35,008,693 |
$75,927,636 |
Sudan (Southern Sector) |
Sub-CCM |
Approved: Category 2 |
TB |
$7,061,337 |
$17,598,282 |
Suriname | CCM | Not approved: Category 3 | HIV/AIDS | $4,759,904 | $9,186,152 |
Suriname |
CCM |
Approved: Category 2 |
Malaria |
$2,409,000 |
$4,232,000 |
Swaziland |
CCM |
Approved: Category 2 |
HIV/AIDS |
$28,380,316 |
$81,866,490 |
Tanzania | CCM | Not approved: Category 3 | HIV/AIDS | $38,764,078 | $103,554,555 |
Tanzania |
CCM |
Approved: Category 1 |
Malaria |
$20,707,304 |
$52,545,829 |
Thailand | CCM | Not approved: Category 3 | HIV/AIDS | $23,383,543 | $66,182,975 |
Thailand |
CCM |
Approved: Category 1 |
Malaria |
$11,939,346 |
$24,689,670 |
Thailand | CCM | Not approved: Category 3 | TB | $6,491,515 | $19,864,434 |
Timor-Leste |
CCM |
Approved: Category 2 |
Malaria |
$6,866,605 |
$10,328,742 |
Timor-Leste |
CCM |
Approved: Category 2B |
TB |
$2,895,449 |
$7,011,931 |
Togo | CCM | Not approved: Category 3 | HIV/AIDS | $32,449,869 | $84,200,275 |
Uganda |
CCM |
Approved: Category 2B |
HIV/AIDS |
$84,358,482 |
$268,800,980 |
Uganda |
CCM |
Approved: Category 2B |
Malaria |
$51,422,198 |
$125,571,990 |
Uganda | CCM | Not approved: Category 3 | TB | $2,416,931 | $5,144,047 |
Ukraine | CCM | Not approved: Category 3 | TB | $52,827,422 | $94,682,871 |
Uzbekistan | CCM | Not approved: Category 3 | HIV/AIDS | $7,154,490 | $16,148,648 |
Uzbekistan | CCM | Not approved: Category 3 | Malaria | $2,213,257 | $5,071,312 |
Uzbekistan | CCM | Not approved: Category 3 | TB | $9,538,632 | $30,154,483 |
Vietnam | CCM | Not approved: Category 3 | HIV/AIDS | $13,154,988 | $38,347,083 |
Vietnam |
CCM |
Approved: Category 2 |
Malaria |
$11,926,329 |
$29,977,899 |
West Bank and Gaza |
Non-CCM (UN Theme Group on HIV/AIDS) |
Approved: Category 2B |
HIV/AIDS |
$5,014,330 |
$10,832,405 |
Yemen |
CCM |
Approved: Category 2 |
Malaria |
$8,140,793 |
$27,862,946 |
Zambia |
CCM |
Approved: Category 2 |
Malaria |
$18,003,233 |
$37,502,022 |
Zambia | CCM | Not approved: Category 3 | TB | $4,112,419 | $24,959,034 |
Zanzibar | CCM | Not approved: Category 3 | Malaria | $5,961,504 | $19,608,490 |
Zimbabwe | CCM | Not approved: Category 3 | Malaria | $26,225,739 | $48,511,090 |
Zimbabwe | CCM | Not approved: Category 3 | TB | $11,247,899 | $25,586,720 |
Table 7: Round 7 results for regional applicants
Region |
Applicant |
Decision |
Component |
Budget Years 1-2 |
Budget Years 1-5 |
Cook Islands, Micronesia, Kiribati, Marshall Islands, Nauru, Nieu, Palau, Samoa, Solomon Islands, Tonga, Tuvalu and Vanuatu |
Regional Coordinating Mechanism (MCWP) |
Approved: Category 2 |
HIV/AIDS |
$10,710,982 |
$25,295,384 |
Cook Islands, Micronesia, Kiribati, Marshall Islands, Nauru, Nieu, Palau, Samoa, Solomon Islands, Tonga, Tuvalu and Vanuatu |
Regional Coordinating Mechanism (MCWP) |
Approved: Category 2B |
TB |
$5,684,067 |
$13,353,203 |
Bangladesh, India and Nepal | Regional Org. (CARE) | Not approved: Category 3 | HIV/AIDS | $23,893,276 | $74,571,728 |
Bangladesh, India and Nepal | Regional Org. (PSI) | Not approved: Category 3 | HIV/AIDS | $11,058,387 | $30,192,838 |
Bolivia, Colombia, Ecuador, Paraguay, Peru and Uruguay | Regional Org. (REDLA+) | Not approved: Category 3 | HIV/AIDS | $21,138,400 | $50,059,500 |
Brunei, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam | Regional Org. (ASEAN) | Not approved: Category 4 | HIV/AIDS | $34,807,826 | $89,393,697 |
Cameroon, CAR, Congo, Gabon, Equatorial Guinea | Regional Org. (CEEAC) | Not approved: Category 4 | HIV/AIDS | $7,170,604 | $18,109,467 |
El Salvador, Honduras, Nicaragua and Panama |
Regional Org. (REDCA+) |
Approved: Category 2B |
HIV/AIDS |
$1,849,200 |
$6,369,850 |